The Union-North America Region (NAR) is the regional arm of the International Union against Tuberculosis and Lung Disease (The Union), a global public health organization with the vision to provide health solutions to the poor. BC Lung is an organizational member of The Union and acts as the Secretariat, organizing and hosting The Union-NAR's annual conference in consultation with the Executive Committee.
The next annual conference will be held April 16-19, 2024 in Baltimore, Maryland, USA
2024 NAR/NTCA Tuberculosis Conference
April 16-19, 2024 Baltimore, MD |
![]() |
|
CALL FOR POSTER ABSTRACTS Deadline for Submissions: November 28, 2023
POSTER ABSTRACT SUBMISSION
We welcome the submission of poster abstracts containing research on all aspects of tuberculosis prevention and care, including epidemiological, clinical, basic science, nursing, social, behavioral, psychosocial, and educational studies, as well as outcomes of program initiatives to address issues like health equity/health disparities and the programmatic response to the recent influx of immigrants into North America. Abstracts must be submitted in accordance with these guidelines.
Poster Presentations
Abstract Content
Abstracts that do not adhere to the required format and work limit will be excluded from consideration.
Abstracts may involve scientific research or public health practice, in the following categories:
Category 1: Scientific research This category includes clinical, programmatic translational, and operational research.
It is recommended that the abstracts in Category 1 be organized using the following sections:
Category 2: Public health practice/education and training This category includes, but is not limited to, the following: TB clinical care, including new treatment regimens, TB epidemiology and surveillance, TB nurse case management, LTBI reporting and surveillance, TB outcomes of program initiatives, TB diagnostic and laboratory updates Contact investigations and large outbreak reporting, use of eDOT and other technologies to deliver care.
It is recommended that the abstracts in Category 2 be organized using the following sections (if an abstract cannot address these sections, it is not eligible for submission):
Scoring Criteria Note: The 2024 TB Conference Abstract Committee has elected to embrace The Union (IUATLD) scoring criteria. The scoring rubric can be found here.
Relevance (Weight 1.0) 0-5 points Methods/Intervention or Response (Weight 1.0) 0-5 points Results/Impact (Weight 1.0) 0-5 points Clarity of the Message (Weight 0.5) 0-5 points Originality (Weight 0.5) 0-5points Total: 20 points
Top Scoring Abstract Award This award will be given to the abstract with the highest score based on the scoring system and submitted by a student, trainee, fellow, or a junior professional (with < 5 years of professional experience in TB Care and Prevention). This includes nurses, physicians, epidemiologists, public health professionals, researchers, etc.
Submission We are developing an online portal for submission of the 2023 poster abstracts. We anticipate that the portal will be open by early November. Deadline to submit is November 28, 2023.
Use of Non-stigmatizing Language The Union-NAR and NTCA are committed to promoting patient-centered, non-stigmatizing language in conference abstracts and presentations, and therefore requests that you follow the guidance laid out in the Stop TB Partnership’s publication: Suggested Language and Usage for Tuberculosis (TB) Care, Communications and Publications.
Deadline for Submission: November 28, 2023
Notification
In addition to the opportunity to submit poster abstracts, the 2024 TB Conference will also include opportunities to discuss challenging clinical cases and challenging programmatic issues facing TB programs with a panel of TB experts. Additional information about this opportunity will be shared soon.
For Additional information, contact: Menn Biagtan, MD, MPH Conference Secretariat T: 604.731.5864
Sherry Brown NTCA TB Conference Coordinator T: 678-503-0503 |
2023 NAR Conference Archive:
POSTGRADUATE COURSE 1:
A New Tool You Can Use to Enhance Your Literacy (Ms. Jennifer Woolley)
How to Have a Powerful Meeting with Decision Makers (Ms. Leigh Raithby, Dr. Elizabeth Rea)
POSTGRADUATE COURSE 2:
Introduction to Implementation Science and Why It Is Relevant to TB (Dr. Christopher Hoffmann)
Implementation Science and TB Preventative Therapy (TPT) (Dr. Patrick Sullivan)
Panel Discussion: Bringing Implementation Science to Public Health Programs
THE GEORGE COMSTOCK LECTURE:
STOP TB SESSION: Implementation in a Post-Pandemic World:
The Updated Global Plan to End TB (Dr. Paula Fujiwara)
Pakistan's Experience with Building an Enhanced Digital TB Surveillance System (Dr. Syed Karam Shah)
Using Public-Private Partnerships to Help End TB (Ms. Petra Heitkamp)
Industry Sponsored Satellite Symposium (QIAGEN)
Nursing and Allied Health Sponsored Session: Community Engagement to Build Trust & Transform Health Systems:
Award Ceremony:
Challenging Cases Pt. 1:
Case #1 (Dr. James Gaensbauer)
Case #2 (Dr. Imelda Villarosa)
TB and Pregnancy Session:
Case Presentation (Dr. Rachel Dwilow)
TB Infection in Pregnancy: Novel Insights into Immunology and Prevention (Dr. Jyoti Mathad)
Best Practices for the Care of Pregnant and Peripartum People with DR-TB (Dr. Jennifer Furin)
The Beyond TB Lecture: Novel Strategies for Wastewater Surveillance (Dr. Amy Kirby)
TB Science: What's Hot?
Making Cough Count in Tuberculosis (Dr. Simon Grandjean Lapierre)
Innovations in Non-Sputum-Based TB Diagnostics in Adults and Children (Dr. Tania Thomas)
Epidemiology of TB Transmission in the United States (Dr. Sourya Shrestha)
Challenging Cases Pt. 2:
Case #3 (Ms. Sarah Silverberg)
Subclinical TB: Challenges in Diagnosis, Treatment, and Transmission:
Overview: Subclinical TB and Its Global Burden (Dr. Emily Kendall)
The Role of Subclinical TB in Transmission (Dr. Barun Mathema)
Will Subclinical TB Hinder TB Elimination in North America? (Dr. Jonathon Campbell)
General Assembly (Dr. Kevin Schwartzman)
Clinical Trials Update:
TRUNCATE (2m DS-TB) (Dr. Nick Paton)
TB PRACTECAL: Final Clinical Trials Results (Dr. Bern-Thomas Nyang'wa)
STREAM Stage 2: Week 76 Results (Dr. ID Rusen)
View the conference program HERE.
View the abstracts HERE.
View the conference evaluation form HERE.
A Message from Dr. Jonathan Golub, 2022 Program Chair/Vice President, The Union-NAR
We hope you will join us in Vancouver for the END TB: 27th Annual Conference of The Union - North America Region! Our multidisciplinary planning committee has assembled an engaging lineup of speakers that will cover timely topics in TB prevention and care, including the updated Global Plan to End TB, TB and pregnancy, subclinical TB, community engagement, recent therapeutic trials, and novel diagnostics. We are also thrilled to have Dr. Barbara Seaworth and Dr. Amy Kirby as our keynote speakers for the George Comstock Lecture and the Beyond TB Lectures respectively. This year we have expanded our programming on challenging clinical TB cases chaired by our multidisciplinary expert panel. We also hope you will join us early for our free pre-conference postgraduate workshops on research literacy and advocacy for clinicians, researchers and survivors, and an introduction to implementation science. We look forward to welcoming you in Vancouver, along with a diverse group of TB advocates, survivors, scientists, clinicians, and program managers, to network and discuss the latest in TB.
2023 Lifetime Achievement Awards
Congratulations to our Lifetime Achievement Awardees: Dr. Max Salfinger and Dr. Charles Peloquin
2023 Early Career Investigator Award
Congratulations to our Early Career Investigator Awardee: Dr. Simon Grandjean Lapierre
CALL FOR SPONSORSHIPS
Looking for sponsors for this year's NAR Conference. Connect exhibitors and sponsors with delegates leading the work in TB and lung health around the world. View our sponsorship packages to see what fits you best.
NAR CHARTER
This charter governs the North America Region (NAR) established by the General Assembly of the International Union Against Tuberculosis and Lung Disease (The Union).
CONFERENCE ARCHIVES